As the popularity of GLP-1 receptor agonists (GLP-1 RAs) continues to rise, over 15 million obese patients are getting benefits
Patients were followed until the first of study end, disenrollment, development of kidney failure or kidney cancer, or death (ESM Fig
A healthcare provider or Registered Dietitian can help you adjust your plan accordingly
You also might experience some mild side effects like nausea, but those will likely pass in coming days, she says
You can take semaglutide as a once-weekly injection or an oral pill, offering flexibility that fits your lifestyle
Baishali Nath | Mon Apr 27 2026 Semaglutide has become one of the most talked-about therapies in modern metabolic carenot just for its effectiveness, but for its ability to address two major health concerns simultaneously: type 2 diabetes and obesity